p21Cip1 up-regulated during histone deacetylase inhibitor-induced CD4+ T-cell anergy selectively associates with mitogen-activated protein kinases

Immunology

Volumn 129, Issue 4, 2010, Pages 589-599

  Dagtas, Ayse Selma ^a   Gilbert, Kathleen M ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Anergy; Signalling signal transduction; T cells; Tolerance

Indexed keywords

BUTYRIC ACID; CELL NUCLEUS ANTIGEN; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLIN DEPENDENT KINASE INHIBITOR 1; HISTONE DEACETYLASE INHIBITOR; INTERLEUKIN 12; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHOPROTEIN; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CD4+ T LYMPHOCYTE; CELL CYCLE; CELL PROLIFERATION; CLONAL ANERGY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TH1 CELL; UPREGULATION;

ANIMALS; BUTYRATES; CD4-POSITIVE T-LYMPHOCYTES; CLONAL ANERGY; CYCLIN-DEPENDENT KINASE INHIBITOR P21; HISTONE DEACETYLASE INHIBITORS; INTERLEUKIN-2; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MALE; MICE; MICE, INBRED C57BL; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-JUN; TRANSCRIPTION FACTOR AP-1; UP-REGULATION;

EID: 77949358361     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2009.03161.x     Document Type: Article

References (45)

1. Gilbert KM, Ernst DN, Hobbs MV, Weigle WO. Effects of tolerance induction on early cell cycle progression by Th1 clones. Cell Immunol 1992; 141:362-72.
2. Powell JD, Lerner CG, Schwartz RH. Inhibition of cell cycle progression by rapamycin induces T cell clonal anergy even in the presence of costimulation. J Immunol 1999; 162:2775-84.
3. Boussiotis VA, Freeman GJ, Taylor PA, Berezovskaya A, Grass I, Blazar BR, Nadler LM. p27kip1 functions as an anergy factor inhibiting interleukin 2 transcription and clonal expansion of alloreactive human and mouse helper T lymphocytes. Nat Med 2000; 6:290-6.
4. Greenwald RJ, Boussiotis VA, Lorsbach RB, Abbas AK, Sharpe AH. CTLA-4 regulates induction of anergy in vivo. Immunity 2001; 14:145-55.
5. Gilbert KM, Weigle WO. Th1 cell anergy and blockade in G1a phase of the cell cycle. J Immunol 1993; 151:1245-54.
6. Edens RE, Dagtas S, Gilbert KM. Histone deacetylase inhibitors induce antigen specific anergy in lymphocytes: a comparative study. Int Immunopharmacol 2006; 6:1673-81.
7. Gilbert KM, Boger S, Fifer EK. Butyric acid derivate induces allospecific T cell anergy and prevents graft-versus-host disease. Immunopharmcol Immunotoxicol 2002; 25:13-27.
8. kip1. J Immunol 2001; 166:952-8.
9. Jackson SK, DeLoose A, Gilbert KM. The ability of antigen, but not IL-2, to promote n-butyrate-induced Th1 cell anergy is associated with increased expression and altered association patterns of cyclin dependent kinase inhibitors. Immunology 2002; 106:486-95.
10. WAF1 expression and gene-associated histone acetylation. Proc Natl Acad Sci USA 2000; 97:10014-9.
11. cip1. Immunopharmcol Immunotoxicol 2005; 27:545-64.
12. Harper JW, Elledge SJ, Keyomarsi K. Inhibition of cyclin-dependent kinase by p21. Mol Biol Cell 1995; 6:387-400.
13. Moore KS, Sullivan K, Tan EM, Prystowsky MB. Proliferating cell nuclear antigen/cyclin is an interleukin 2-responsive gene. J Biol Chem 1987; 262:8447-50.
14. Lorens JB, Bennett MK, Pearsall DM et al. Retroviral delivery of peptide modulators of cellular functions. Mol Ther 2000; 1:438-47.
15. Shim J, Lee H, Park J, Kim H, Choi EJ. A non-enzymatic p21 protein inhibitor of stress-activated protein kinases. Nature 1996; 381:804-6.
16. waf1 and p53: modulation of JNK1 activity. Mol Carcinog 2003; 36:38-44.
17. waf1 is dynamically associated with JNK in human T-lymphocytes during cell cycle progression. J Cell Sci 1998; 111:2247-55.
18. + T cells have defective expression and function of the activating protein-1 transcription factor. J Immunol 1998; 161:5930-6.
19. 2-terminal kinase and mitogen-activated kinase signaling pathways. J Exp Med 1996; 183:2017-23.
20. Kang SM, Beverly B, Tran AC, Brorson K, Schwartz RH, Lenardo MJ. Transactivation by AP-1 is a molecular target of T cell clonal anergy. Science 1992; 257:1134-8.
21. Gilbert KM, Hoang KD, Weigle WO. Th1 and Th2 clones differ in their response to a tolerogenic signal. J Immunol 1990; 144:2063-71.
22. Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells. Nat Cell Biol 2001; 3:245-52.
23. Cip1. Nature 1995; 375:159-61.
24. Han Z, Boyle DL, Chang L, Bennett B, Karin M, Yang L, Manning AM, Firestein GS. c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis. J Clin Invest 2001; 108:73-81.
25. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 1993; 75:805-16.
26. LaBaer J, Garrett MD, Stevenson LF, Slingerland JM, Sandhu C, Chou HS, Fattaey A, Harlow E. New functional activities for the p21 family of CDK inhibitors. Genes Dev 1997; 11:847-62.
27. Zhang H, Hannon GJ, Beach D. p21-containing cyclin kinases exist in both active and inactive states. Genes Dev 1994; 8:1750-9.
28. Santiago-Raber ML, Lawson BR, Dummer W, Barnhouse M, Koundouris S, Wilson CB, Kono DH, Theofilopoulos AN. Role of cyclin kinase inhibitor p21 in systemic autoimmunity. J Immunol 2001; 167:4067-74.
29. CIP1/WAF1 controls proliferation of activated/memory T cells and affects homeostasis and memory T cell responses. J Immunol 2007; 178:2296-306.
30. Waga S, Li R, Stillman B. p53-induced p21 controls DNA replication. Leukemia 1997; 11(Suppl. 3):321-3.
31. Li R, Waga S, Hannon GJ, Beach D, Stillman B. Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repair. Nature 1994; 371:534-7.
32. Kurki P, Lotz M, Ogata K, Tan EM. Proliferating cell nuclear antigen (PCNA)/cyclin in activated human T lymphocytes. J Immunol 1987; 138:4114-20.
33. Rincon M. MAP-kinase signaling pathways in T cells. Curr Opin Immunol 2001; 13:339-45.
34. Derijard B, Hibi M, Wu IH, Barrett T, Su B, Deng T, Karin M, Davis RJ. JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 1994; 76:1025-37.
35. + T cells. Science 1996; 271:1272-5.
36. Matsuda S, Moriguchi T, Koyasu S, Nishida E. T lymphocyte activation signals for interleukin-2 production involve activation of MKK6-p38 and MKK7-SAPK/JNK signaling pathways sensitive to cyclosporin A. J Biol Chem 1998; 273:12378-82.
37. 2-terminal kinase pathway. Science 1998; 280:945-9.
38. Rowell EA, Wang L, Hancock WW, Wells AD. The cyclin-dependent kinase inhibitor p27Kip1 is required for transplantation tolerance induced by costimulatory blockade. J Immunol 2006; 177:5169-76.
39. (Kip1). Eur J Immunol 2001; 31:3737-46.
40. Finzer P, Kuntzen C, Soto U, zur HH, Rosl F. Inhibitors of histone deacetylase arrest cell cycle and induce apoptosis in cervical carcinoma cells circumventing human papillomavirus oncogene expression. Oncogene 2001; 20:4768-76.
41. Reddy P, Sun Y, Toubai T et al. Histone deacetylase inhibition modulates indoleamine 2,3-dioxygenase-dependent DC functions and regulates experimental graft-versus-host disease in mice. J Clin Invest 2008; 118:2562-73.
42. Tao R, de Zoeten EF, Ozkaynak E et al. Deacetylase inhibition promotes the generation and function of regulatory T cells. Nat Med 2007; 13:1299-307.
43. Chen D, Heath V, O'Garra A, Johnston J, McMahon M. Sustained activation of the raf-MEK-ERK pathway elicits cytokine unresponsiveness in T cells. J Immunol 1999; 163:5796-805.
44. Goulvestre C, Chereau C, Nicco C, Mouthon L, Weill B, Batteux F. A mimic of p21WAF1/CIP1 ameliorates murine lupus. J Immunol 2005; 175:6959-67.
45. Balomenos D, Martin-Caballero J, Garcia MI, Prieto I, Flores JM, Serrano M, Martinez-A C. The cell cycle inhibitor p21 controls T cell proliferation and sex-linked lupus development. Nat Med 2000; 6:171-6.